Advertisement - Members don't see this ad
Sorry to create a thread that doesn't include "IM IN 9TH GRADE AND GOT A 91% IN ENGLISH CAN I MATCH EM?!?!?" or "Hey you emergency doctors are stupid and admitted a not appendicitis" but...
Got into a discussion the other day.
Had a patient, 60 something, lung cancer currently on chemo, last chemo one week prior. Came to ED for DOE somewhat worse than baseline, felt nebs at home weren't making him feel better. Patient afebrile, normal vitals, baseline SpO2. Patient really doesn't look bad, no respiratory distress, hes awake, alert, joking with us.
Checked labs, only thing abnormal was CBC: WBC 6, 28% bands. CXR unremarkable. Gave hour long duoneb, steroids, Patient feels much better. Ambulating in ED, feels back to baseline.Called patient's oncologist, who says the patient is on one of the GM-CSF medications and that is why he would be expected to have such a significant bandemia. He is okay with the patient going home if he is feeling better and seeing him in the next few days. Patient wants to go home too. He is (understandably) sick of the hospital.
My attending is okay with dc as well, but she orders a set of blood cultures to be drawn prior to DC.
So what are your thoughts on this for these borderline patients? Patients look good, think they're probably going to be okay at home, but significant comorbidities. Little extra insurance to make sure that if something bad is developing maybe we can get them back sooner?
Discussed this thought process with another attending. He was against the practice. His reasoning was from a medicolegal standpoint - that if we are sending BCs prior to d/c it looks like we are saying that we are still reasonably concerned about this patient going home and that if we have that concern we should be hospitalizing them for IV abx and waiting for the cultures to come back.
The downsides I see to this are: false positives - how often do you get 1 out of 4 bottles with G+ cocci that ends up being coag negative staph but now you're stuck with it. Also, inability to actually reach the patient should they come back positive. I am also aware of the trend away from routine blood cultures on every patient with an infection as they end up being low yield a majority of the time, costly, have a lot of false positives, and don't actually impact care or outcome.
Upsides: Extra insurance/protection against some hidden badness in a baseline sick patient who otherwise looks well.
Thoughts? Anyone do this?
Got into a discussion the other day.
Had a patient, 60 something, lung cancer currently on chemo, last chemo one week prior. Came to ED for DOE somewhat worse than baseline, felt nebs at home weren't making him feel better. Patient afebrile, normal vitals, baseline SpO2. Patient really doesn't look bad, no respiratory distress, hes awake, alert, joking with us.
Checked labs, only thing abnormal was CBC: WBC 6, 28% bands. CXR unremarkable. Gave hour long duoneb, steroids, Patient feels much better. Ambulating in ED, feels back to baseline.Called patient's oncologist, who says the patient is on one of the GM-CSF medications and that is why he would be expected to have such a significant bandemia. He is okay with the patient going home if he is feeling better and seeing him in the next few days. Patient wants to go home too. He is (understandably) sick of the hospital.
My attending is okay with dc as well, but she orders a set of blood cultures to be drawn prior to DC.
So what are your thoughts on this for these borderline patients? Patients look good, think they're probably going to be okay at home, but significant comorbidities. Little extra insurance to make sure that if something bad is developing maybe we can get them back sooner?
Discussed this thought process with another attending. He was against the practice. His reasoning was from a medicolegal standpoint - that if we are sending BCs prior to d/c it looks like we are saying that we are still reasonably concerned about this patient going home and that if we have that concern we should be hospitalizing them for IV abx and waiting for the cultures to come back.
The downsides I see to this are: false positives - how often do you get 1 out of 4 bottles with G+ cocci that ends up being coag negative staph but now you're stuck with it. Also, inability to actually reach the patient should they come back positive. I am also aware of the trend away from routine blood cultures on every patient with an infection as they end up being low yield a majority of the time, costly, have a lot of false positives, and don't actually impact care or outcome.
Upsides: Extra insurance/protection against some hidden badness in a baseline sick patient who otherwise looks well.
Thoughts? Anyone do this?